TMDX Q4 2025 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$161M+32.2% YoY

Gross Profit

$93M58.1% margin

Operating Income

$21M13.2% margin

Net Income

$105M65.6% margin

EPS (Diluted)

$2.59

QoQ Revenue Growth

+11.8%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

$19M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$595M

Stockholders' Equity

$473M

Cash & Equivalents

$488M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$161M	$122M	+32.2%
Gross Profit	$93M	$72M	+29.7%
Operating Income	$21M	$9M	+146.1%
Net Income	$105M	$7M	+1436.9%

Revenue Segments

Product

$100M100%